Scalco, RS;
Morrow, J;
Skorupinska, I;
Manole, AA;
Bellin, A;
Ricciardi, F;
Matthews, E;
... Fialho, D; + view all
(2018)
EPR2165: RCT assessing 2mg bumetanide as a therapeutic agent for a focal attack of weakness in Hypokalaemic Periodic Paralysis (HypoPP).
Presented at: 4th Congress of the European Academy of Neurology, Lisbon, Portugal.
Preview |
Text
Scalco_EAN 2018 Bumetanide in HypoPP.pdf - Accepted Version Download (68kB) | Preview |
Archive Staff Only
View Item |